Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

With the recent Food and Drug Administration approval of Quartette, a new extended regimen oral contraceptive (OC) from Teva Pharmaceuticals of North Wales, PA, providers have more options to present to women considering this form of birth control.

The options expand for extended regimen OCs